Furthermore, a lot of effectively established adverse prognostic markers, like U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, missing their destructive result in individuals handled with VO. The one factor that remained predictive of a shorter development-absolutely free survival On this cohort o